Evidence map›Paper›PMID 39849386›Full record

ArticleBMC nephrology2025

Prevalence of chronic kidney disease in Saudi Arabia: an epidemiological population-based study.

Mohammed A Alshehri, Husain Y Alkhlady, Zuhier A Awan, Mohammed Ridha Algethami, Hadiah B Al Mahdi, Hussam Daghistani, Khalid Orayj

Abstract read
In one paragraph

Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammed A AlshehriNephrology section, Internal Medicine Department, College of Medicine, King Khalid University, 9217, Al Talha St., Al Aqiq Dist., Abha, 61421, Saudi Arabia. Mohd.shehri@gmail.com.
Husain Y AlkhladyHaematology section, Internal Medicine Department, College of Medicine, King Khalid University, Abha, 61421, Saudi Arabia.
Zuhier A AwanDepartment of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University Jeddah, Jeddah, 22254, Saudi Arabia.
Mohammed Ridha AlgethamiDepartment of Family and Community Medicine, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
Hadiah B Al MahdiAlBorg Medical Laboratories, AlBorg Diagnostics, Research and Development Unit, Jeddah, Saudi Arabia.
Hussam DaghistaniDepartment of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University Jeddah, Jeddah, 22254, Saudi Arabia.
Khalid OrayjDepartment of Clinical Pharmacy, King Khalid University, 61421, Abha, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD) is a prevalent global health issue affecting millions of patients worldwide, impacting quality of life, impeding physical and psychological well-being, causing financial stress, and increasing mortality rates. This study aimed to highlight the prevalence of CKD and its associated risk factors across Saudi Arabia.

methodThis is a cross-sectional study conducted from 2015 to 2022, using data from 42 branches of a major network of diagnostic laboratories in Saudi Arabia, covering the country's 13 administrative areas.

resultsThe mean age was 40.35 ± 14.5 years. The highest proportion of participants resided in the Makkah region at 35.77%, followed by the Riyadh region at 25.75%. The overall prevalence of CKD was 4.76%, with most having CKD in stage 3 (3.5%). The prevalence of CKD was higher among males compared to females (5.83% vs. 3.88%) and increased significantly with age, being 0.45% among participants aged 18-29 years and reaching 50.94% among participants aged 90 years or older. Predictors of CKD included increasing age, male sex, administrative area (Makkah 1.40 [95% CI:1.26-1.55], Jazan 1.34 [95% CI:1.18-1.52], Najran 0.47 [95% CI, 0.39-0.57], Alqasim 0.73 [95% CI, 0.64-0.82]), and a high hemoglobin A1C. CKD in Saudi Arabia is influenced by various demographic and geographic determinants contributing to its prevalence and associated burden on the population.

conclusionThese findings emphasize the need for targeted screening and prevention strategies, especially for at-risk populations. Continued surveillance, early detection, and effective management are crucial to reducing CKD's burden and improving kidney health outcomes in Saudi Arabia. Further research is essential to better understand the disease's regional and demographic drivers.

Indexed as

Renal Insufficiency, ChronicAdolescentAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceRisk FactorsSaudi ArabiaYoung AdultChronic kidney disease, PrevalenceDiabetesHypertensionObesityScreening

Identifiers

PMID39849386
PMCPMC11759450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.